Baird Medical Investment Holdings (BDMDW) Inventory Average (2024 - 2025)
Baird Medical Investment Holdings' quarterly Inventory Average came in at $488960.5 in Q4 2025, down 24.45% year-on-year from $647181.5 in Q4 2024, and down 17.73% quarter-over-quarter from $594357.5 in Q2 2025.
Baird Medical Investment Holdings has reported Inventory Average for 2 years, with the latest figure at $488960.5 in Q4 2025.
- For the quarter ending Q4 2025, Inventory Average fell 24.45% year-over-year to $488960.5; the trailing twelve-month figure through Dec 2025 stood at $488960.5 (down 24.45% YoY), and the FY2025 full-year result was $1.2 million, down 2.33% from the prior year.
- Inventory Average for Q4 2025 stood at $488960.5, down from $594357.5 in the prior quarter.
- The five-year high for Inventory Average was $647181.5 in Q4 2024, with the low at $488960.5 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.36 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.23 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.12 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.49 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 661.35 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 652.65 Mn |
| 10 | Baird Medical Investment Holdings | - | - | - | 488,960.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 488,960.50 |
| Jun 30, 2025 | 594,357.50 |
| Dec 31, 2024 | 647,181.50 |
| Jun 30, 2024 | 570,177.50 |